Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Rasagiline Mesylate Patent Expiration

Rasagiline Mesylate is Used for managing the symptoms of Parkinson's disease. It was first introduced by Teva Neuroscience Inc in its drug Azilect on May 16, 2006. 13 different companies have introduced drugs containing Rasagiline Mesylate.


Rasagiline Mesylate Patents

Given below is the list of patents protecting Rasagiline Mesylate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Azilect US7815942 Rasagiline formulations of improved content uniformity Aug 27, 2027 Teva
Azilect US7572834 Rasagiline formulations and processes for their preparation Dec 05, 2026 Teva
Azilect US5453446 Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease. Feb 07, 2017

(Expired)

 Teva
Azilect US6126968 Stable compositions containing N-propargyl-1-aminoindan Sep 18, 2016

(Expired)

 Teva
Azilect US5532415 R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof Jul 02, 2013

(Expired)

 Teva



Rasagiline Mesylate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Rasagiline Mesylate Generic API Manufacturers

Several generic applications have been filed for Rasagiline Mesylate. The first generic version for Rasagiline Mesylate was by Watson Laboratories Inc and was approved on Jul 1, 2013. And the latest generic version is by Torrent Pharmaceuticals Ltd and was approved on May 5, 2025.

Given below is the list of companies who have filed for Rasagiline Mesylate generic, along with the locations of their manufacturing plants worldwide.


1. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Prescription ORAL AB Oct 30, 2017
EQ 1MG BASE

tablet Prescription ORAL AB Oct 30, 2017





2. APOTEX INC

Apotex Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Discontinued ORAL N/A Sep 12, 2013
EQ 1MG BASE

tablet Discontinued ORAL N/A Sep 12, 2013


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
Toronto Apotex Inc.
Richmond Hill Apotex Inc.
North York Apotex Inc.





3. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Prescription ORAL AB May 15, 2017
EQ 1MG BASE

tablet Prescription ORAL AB May 15, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.

Country City Firm Name
United States
East Windsor Aurobindo Pharma USA Inc





4. CARNEGIE

Carnegie Pharmaceuticals Llc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Carnegie.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Discontinued ORAL N/A Nov 18, 2021
EQ 1MG BASE

tablet Discontinued ORAL N/A Nov 18, 2021


Manufacturing Plant Locations
New

Carnegie's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Carnegie as present at those locations.

Country City Firm Name
United States
Delran Carnegie Pharmaceutical Llc
Pittsburgh Carnegie Science Center Henry J. Buhl Planetarium





5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

tablet Prescription ORAL AB Jul 27, 2018
EQ 0.5MG BASE

tablet Prescription ORAL AB Jul 27, 2018





6. INDOCO

Indoco Remedies Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Indoco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

tablet Prescription ORAL AB Oct 4, 2019
EQ 0.5MG BASE

tablet Prescription ORAL AB Oct 4, 2019


Manufacturing Plant Locations
New

Indoco's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Indoco as present at those locations.

Country City Firm Name
India
Taluka Khalapur, District Raigad Indoco Remedies Limited
Verna Indoco Remedies Limited (Plant I)
Verna Indoco Remedies Limited
Navi Mumbai Indoco Remedies Limited





7. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Prescription ORAL AB Jun 28, 2024
EQ 1MG BASE

tablet Prescription ORAL AB Jun 28, 2024





8. MICRO LABS

Micro Labs Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

tablet Prescription ORAL AB Mar 29, 2019
EQ 0.5MG BASE

tablet Prescription ORAL AB Mar 29, 2019


Manufacturing Plant Locations
New

Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.

Country City Firm Name
India
Bengaluru Micro Labs Limited, Central Analytical Laboratory
Verna Micro Labs Limited
Bengaluru Micro Labs Limited
Bangalore Micro Labs Limited





9. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

tablet Prescription ORAL AB Mar 15, 2016
EQ 0.5MG BASE

tablet Prescription ORAL AB Mar 15, 2016





10. SKG PHARMA

Skg Pharma Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Skg Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Prescription ORAL AB Apr 9, 2024
EQ 1MG BASE

tablet Prescription ORAL AB Apr 9, 2024





11. TORRENT

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Prescription ORAL AB May 5, 2025
EQ 1MG BASE

tablet Prescription ORAL AB May 5, 2025


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Bharuch Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
Pithampur Torrent Pharmaceuticals Limited
United States
Kalamazoo Torrent Pharma Inc.
Basking Ridge Torrent Pharma Inc.





12. WATSON LABS INC

Watson Laboratories Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Discontinued ORAL N/A Jul 1, 2013
EQ 1MG BASE

tablet Discontinued ORAL N/A Jul 1, 2013